Business
Divi’s Laboratories Q4 Result FY26: API Recovery Drives a Strong Earnings Comeback
The long wait for pharmaceutical investors is finally over as Divi’s Laboratories Limited announced its Q4 FY26 results on May…
Business
Mankind Pharma Q4 Result FY26: Profit Jumps 30% as Chronic Portfolio Fires on All Cylinders
India’s pharmaceutical sector witnessed another strong earnings surprise as Mankind Pharma Limited delivered an impressive Q4 FY26 performance that reinforced…
Business
Zydus Lifesciences Q4 Result FY26: Stellar Earnings Beat, ₹1,100 Crore Buyback Sparks Pharma Rally
Pharmaceutical giant Zydus Lifesciences sent shockwaves through Dalal Street today, turning what was expected to be a routine Q4 FY26…
Business
Gland Pharma Q4 Result FY26: Profit Doubles, Margins Expand and the Turnaround Story Gets Stronger
Introduction: Gland Pharma’s Blowout Quarter Changes Market Sentiment Injectables major Gland Pharma delivered one of the strongest pharmaceutical earnings surprises…